CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 124, Issue 7, Pages 2977-2987
Publisher
American Society for Clinical Investigation
Online
2014-06-02
DOI
10.1172/jci73174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasticity in programming of effector and memory CD8+T-cell formation
- (2015) Ramon Arens et al. IMMUNOLOGICAL REVIEWS
- TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
- (2013) Q. Zhang et al. BLOOD
- S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma
- (2012) Y. Liu et al. BLOOD
- Immunology beats cancer: a blueprint for successful translation
- (2012) Drew M Pardoll NATURE IMMUNOLOGY
- Targeting Regulatory T Cells in Cancer
- (2011) W. L. Byrne et al. CANCER RESEARCH
- STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
- (2011) A. Scuto et al. CANCER RESEARCH
- Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
- (2011) Lee Adam Wheeler et al. JOURNAL OF CLINICAL INVESTIGATION
- Progress Toward In Vivo Use of siRNAs-II
- (2011) Garrett R Rettig et al. MOLECULAR THERAPY
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells
- (2010) A. Herrmann et al. CANCER RESEARCH
- Targeting STAT3 in Adoptively Transferred T Cells Promotes Their In Vivo Expansion and Antitumor Effects
- (2010) M. Kujawski et al. CANCER RESEARCH
- Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3
- (2010) Jason Brayer et al. IMMUNOLOGY LETTERS
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
- (2009) Marcin Kortylewski et al. NATURE BIOTECHNOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Role of Stat3 in suppressing anti-tumor immunity
- (2008) Marcin Kortylewski et al. CURRENT OPINION IN IMMUNOLOGY
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search